Literature DB >> 11379048

Effects of the aqueous extract of epimedii herba on the antibody responses in mice.

J H Kim1, Y J Mun, S J Im, J H Han, H S Lee, W H Woo.   

Abstract

Antibodies and cytokines in serum were detected in male ICR mice treated with the aqueous extract of Epimedii Herba (AEEH) at doses of 40, 120 and 360 mg/kg orally for 2 weeks. Effects of AEEH on antibody forming responses were assessed by enzyme linked immunosorbent assay (ELISA) of immunoglobulin (Ig) levels in serum collected 7 days after priming with ovalbumin (OVA) in complete Freund's adjuvant (CFA) or immediately without priming at week 2. The relative spleen weight was significantly increased by AEEH, compared with controls, especially at a dose of 120 mg/kg of it after priming with OVA and 40 mg/kg without priming, respectively. However, body weight gain was slightly decreased in AEEH-fed mice. The enhancement of total serum IgG and IgG1 levels in unprimed mice was statistically significant in mice fed 40 mg/kg AEEH. Total serum IgG2a levels and Il-4 secretion were also statistically augmented by all groups of AEEH treatment. A tendency to marked increase of total serum IgM level and IFN-gamma secretion was also observed in mice fed 40 and 120 mg/kg AEEH but not those fed 360 mg/kg AEEH. When mice were immunized with OVA, furthermore, a marked stimulation of antibody formation and cytokines secretion was observed in all groups of AEEH-fed mice compared with controls. These findings indicate that AEEH at therapeutic concentrations enhances the production of antibodies and cytokines in mice, and the enhancing effects are more marked when the mice were immunized with OVA. Thus, these results suggest that AEEH is effective on Th cell functions, and protective effects on host against immune diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379048     DOI: 10.1016/s1567-5769(01)00030-3

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  UPLC-MS-QTOF analysis and antifungal activity of Cumaru (Amburana cearensis).

Authors:  Maria Tatiana Alves Oliveira; Marcus Vinícius Oliveira Barros de Alencar; Vicente de Paulo Dos Anjos Landim; Geovanna Maria Medeiros Moura; Joelton Igor Oliveira da Cruz; Elizeu Antunes Dos Santos; Henrique Douglas Melo Coutinho; Jacqueline Cosmo Andrade; Irwin Rose Alencar de Menezes; Paulo Riceli Vasconcelos Ribeiro; Edy Sousa de Brito; Erlânio Oliveira de Sousa; Adriana Ferreira Uchoa
Journal:  3 Biotech       Date:  2020-11-23       Impact factor: 2.406

2.  Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions.

Authors:  Junmin Zhou; Jinfeng Wu; Xianghong Chen; Nicole Fortenbery; Erika Eksioglu; Krithika N Kodumudi; Epling-Burnette Pk; Jingcheng Dong; Julie Y Djeu; Sheng Wei
Journal:  Int Immunopharmacol       Date:  2011-01-15       Impact factor: 4.932

3.  Pharmacokinetics, Tissue Distribution, and Metabolism Study of Icariin in Rat.

Authors:  Shunjun Xu; Jiejing Yu; Jingjing Zhan; Liu Yang; Longgang Guo; Yijuan Xu
Journal:  Biomed Res Int       Date:  2017-11-13       Impact factor: 3.411

4.  Determination of Epimedin B in Rat Plasma and Tissue by LC-MS/MS: Application in Pharmacokinetic and Tissue Distribution Studies.

Authors:  Qianru Feng; Shunjun Xu; Jiejing Yu; Shuai Sun; Liu Yang
Journal:  J Anal Methods Chem       Date:  2017-06-01       Impact factor: 2.193

5.  Drug-Drug Interactions Potential of Icariin and Its Intestinal Metabolites via Inhibition of Intestinal UDP-Glucuronosyltransferases.

Authors:  Yun-Feng Cao; Rong-Rong He; Jun Cao; Jian-Xing Chen; Ting Huang; Yong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-16       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.